Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Inspire Medical Systems Inc (NY: INSP )

186.40 +1.63 (+0.88%)
Streaming Delayed Price Updated: 1:08 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 128,743
Open 184.88
Bid (Size) 186.20 (7)
Ask (Size) 186.57 (2)
Prev. Close 184.77
Today's Range 182.14 - 187.15
52wk Range 123.00 - 257.40
Shares Outstanding 27,271,598
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Inspire Medical's Strong 2025 Outlook And Upcoming Inspire V Launch Earns Analyst Upgrade
BofA upgrades Inspire Medical to Buy, setting a $255 price target. The company aims for $950 million in 2025 revenue, with a focus on new product launches and expansion. 
Via Benzinga
In the world of growth stocks, NYSE:INSP shines as a value proposition.
Despite its growth, NYSE:INSP remains within the realm of affordability. 
Via Chartmill

Performance

YTD
-0.77%
-0.77%
1 Month
-8.38%
-8.38%
3 Month
-0.50%
-0.50%
6 Month
+15.42%
+15.42%
1 Year
+35.14%
+35.14%

More News

Read More
7 Analysts Have This To Say About Inspire Medical Systems
Via Benzinga
Why INSPIRE MEDICAL SYSTEMS INC (NYSE:INSP) qualifies as a high growth stock.
Via Chartmill
Analyst Scoreboard: 7 Ratings For Inspire Medical Systems
Via Benzinga
The Analyst Verdict: Inspire Medical Systems In The Eyes Of 7 Experts
Via Benzinga
Terns Pharmaceuticals, Boeing, Tesla And Other Big Stocks Moving Higher On Monday
Via Benzinga
Deep Dive Into Inspire Medical Systems Stock: Analyst Perspectives (6 Ratings)
Via Benzinga
Shopify Posts Upbeat Earnings, Joins Axon Enterprise, Aspen Technology, Illumina, Global Payments And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
INSP Stock Earnings: Inspire Medical Systems Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
INSPIRE MEDICAL ALERT: Bragar Eagel & Squire, P.C. is Investigating Inspire Medical Systems, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
What Analysts Are Saying About Inspire Medical Systems Stock
Via Benzinga
Expert Ratings For Inspire Medical Systems
Via Benzinga
FDA Labels Inspire Medical's Sleep Apnea Nerve Stimulator Recall As Most Serious
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
Via MarketBeat
Exposures Product Safety
ResMed, Coinbase Global, Nvidia And Other Big Stocks Moving Lower On Monday
Via Benzinga
Eli Lilly's Weight-Loss Drug Takes Down ResMed, Inspire Medical — Again
Via Investor's Business Daily
Jim Cramer: Celestica Makes A 'Comeback,' Sell This Movie Theater Stock,
Via Benzinga
7 Undervalued Stocks That Could Triple Your Money by 2026
Via InvestorPlace
Dow Gains 150 Points; Emerson Electric Earnings Top Views
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Why Upstart Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Crude Oil Moves Higher; Inspire Medical Systems Shares Plummet
Via Benzinga
Exposures Fossil Fuels
Why RingCentral Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.